Ginkgo Bioworks Valuation
| DNA Stock | USD 8.46 0.31 3.53% |
At this time, the firm appears to be undervalued. Ginkgo Bioworks Holdings retains a regular Real Value of $9.54 per share. The prevalent price of the firm is $8.46. Our model calculates the value of Ginkgo Bioworks Holdings from evaluating the firm fundamentals such as Current Valuation of 492.38 M, return on equity of -0.5, and Return On Asset of -0.16 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Ginkgo Bioworks' valuation include:
Price Book 0.9493 | Enterprise Value | Enterprise Value Ebitda (1.79) | Price Sales 2.9422 | Enterprise Value Revenue 2.7263 |
Undervalued
Today
Please note that Ginkgo Bioworks' price fluctuation is moderately volatile at this time. Calculation of the real value of Ginkgo Bioworks Holdings is based on 3 months time horizon. Increasing Ginkgo Bioworks' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ginkgo Bioworks is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ginkgo Stock. However, Ginkgo Bioworks' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.46 | Real 9.54 | Target 10.67 | Hype 8.53 |
The real value of Ginkgo Stock, also known as its intrinsic value, is the underlying worth of Ginkgo Bioworks Holdings Company, which is reflected in its stock price. It is based on Ginkgo Bioworks' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ginkgo Bioworks' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ginkgo Bioworks Holdings helps investors to forecast how Ginkgo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ginkgo Bioworks more accurately as focusing exclusively on Ginkgo Bioworks' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Ginkgo Bioworks' intrinsic value based on its ongoing forecasts of Ginkgo Bioworks' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Ginkgo Bioworks' closest peers. If more than one evaluation category is relevant for Ginkgo Bioworks we suggest using both methods to arrive at a better estimate.
Ginkgo Bioworks Cash |
|
Ginkgo Valuation Trend
Comparing Ginkgo Bioworks' enterprise value against its market capitalization is a good way to estimate the value of Ginkgo Bioworks Holdings uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Ginkgo Bioworks Total Value Analysis
Ginkgo Bioworks Holdings is currently estimated to have company total value of 492.38 M with market capitalization of 531.38 M, debt of 467.73 M, and cash on hands of 561.57 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Ginkgo Bioworks fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
492.38 M | 531.38 M | 467.73 M | 561.57 M |
Ginkgo Bioworks Investor Information
About 77.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.95. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ginkgo Bioworks Holdings recorded a loss per share of 6.18. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 20th of August 2024. Based on the key indicators related to Ginkgo Bioworks' liquidity, profitability, solvency, and operating efficiency, Ginkgo Bioworks Holdings is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Ginkgo Bioworks Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ginkgo Bioworks has an asset utilization ratio of 16.48 percent. This suggests that the Company is making $0.16 for each dollar of assets. An increasing asset utilization means that Ginkgo Bioworks Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Ginkgo Bioworks Ownership Allocation
Ginkgo Bioworks Holdings has a total of 48.52 Million outstanding shares. The majority of Ginkgo Bioworks Holdings outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Ginkgo Bioworks to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Ginkgo Bioworks Holdings. Please pay attention to any change in the institutional holdings of Ginkgo Bioworks Holdings as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Ginkgo Bioworks Profitability Analysis
The company reported the last year's revenue of 227.04 M. Reported Net Loss for the year was (547.03 M) with profit before taxes, overhead, and interest of 131.31 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ginkgo Bioworks' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ginkgo Bioworks and how it compares across the competition.
About Ginkgo Bioworks Valuation
The stock valuation mechanism determines Ginkgo Bioworks' current worth on a weekly basis. Our valuation model uses a comparative analysis of Ginkgo Bioworks. We calculate exposure to Ginkgo Bioworks's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ginkgo Bioworks's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 188.5 M | 175.8 M | |
| Pretax Profit Margin | (2.41) | (2.53) | |
| Operating Profit Margin | (2.47) | (2.59) | |
| Net Loss | (2.41) | (2.53) | |
| Gross Profit Margin | 0.83 | 0.57 |
Ginkgo Bioworks Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 51.9 M |
Ginkgo Bioworks Current Valuation Indicators
Valuation refers to the process of determining the present value of Ginkgo Bioworks Holdings and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Ginkgo we look at many different elements of the entity such as Ginkgo's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Ginkgo Bioworks, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Ginkgo Bioworks' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Ginkgo Bioworks' worth.Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |